FDA
approval
· 2013-12-20
FDA Approved: ORENITRAM — Original Application (United Therapeutics Corporation)
Summary
The FDA approved ORENITRAM (treprostinil) under an Original NDA from United Therapeutics, providing an oral formulation for pulmonary arterial hypertension. Thi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ORENITRAM (TREPROSTINIL)